Alto Neuroscience Shares Topline Results from Phase 2 Proof-of-Concept Trial of ALTO-101 and Highlights Ongoing Pipeline Progress Alto Neuroscience, Inc. has announced topline results from its Phase 2 proof-of-concept (POC)…
FORE Biotherapeutics Earns Breakthrough Therapy Designation for Plixorafenib FORE Biotherapeutics, a registration-stage biopharmaceutical company focused on developing precision therapies for cancer, has announced a significant regulatory milestone for its lead…
Shionogi Secures Complete Ownership of Global Rights to RADICAVA (edaravone) Shionogi & Co., Ltd. has announced the successful completion of a major strategic transaction involving the full transfer of rights…
VDYNE Secures FDA IDE Clearance to Launch TRIVITA1 Pivotal Trial for Its Transcatheter Tricuspid Valve Replacement System VDYNE, Inc., a privately held medical device innovator focused on advancing next-generation structural…
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial Evaluating BOT+BAL Combination in MSS/pMMR Metastatic Colorectal Cance Agenus Inc., a clinical-stage immuno-oncology company focused on developing novel therapies…
Biogen’s Acquisition of Apellis Strengthens Immunology and Rare Disease Portfolio While Accelerating Growth and Entry into Nephrology Biogen Inc. and Apellis Pharmaceuticals (Nasdaq: APLS) have announced a definitive agreement under…
Bristol Myers Squibb Strengthens and Expands Commitment to Advancing Equitable Care in Multiple Myeloma as GAAP Initiative Reaches Ten Years Bristol Myers Squibb (NYSE: BMY), a recognized leader in oncology,…
Lilly Announces Acquisition of Centessa Pharmaceuticals to Expand Pipeline in Sleep-Wake Disorder Treatments Eli Lilly and Company and Centessa Pharmaceuticals plc have announced a definitive agreement under which Lilly will…
Submissions Open for the Second Annual Thomas J. Fogarty Prize Recognizing Breakthrough Medtech Innovations Nominations are set to open on April 2, 2026, for the second annual Thomas J. Fogarty…
LumaCyte’s Analytical Method Recognized in Newly Issued ISO Global Standard for Viral Vector Quantification LumaCyte has announced a significant milestone for its proprietary analytical technology, revealing that its approach has…
Bayer Implements U.S. Leadership Restructuring in Pharmaceuticals’ Worldwide Markets to Accelerate Growth Potential Bayer has announced a significant leadership transition within its Pharmaceuticals division, signaling a strategic move to accelerate…
Introduces FFPE-Compatible Barcoding Innovation Enabling Whole Transcriptome Single-Cell Analysis Parse Biosciences, a subsidiary of QIAGEN and a recognized leader in scalable single-cell sequencing technologies, has announced the commercial launch and…